Background Chronic heart failure (HF) is a growing global health challenge. People with HF
experience substantial burden that includes low exercise tolerance, poor health‐related …

Chagas disease (CD) is caused by the flagellate protozoan Trypanosoma cruzi. It is
endemic in Latin America. Nowadays around 6 million people are affected worldwide, and …

SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

A DC (tripanossomíase americana) é entidade mórbida transmissível, potencialmente fatal,
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …

Background We assessed the effects of exercise-based training programs (EBTP) in patients
with chronic Chagas cardiomyopathy (CCC) through a systematic review and meta-analysis …

(1) Background: COVID-19 can lead to many complications, including cardiorespiratory
complications and dysautonomia. This can be assessed by heart rate variability (HRV) …

Chagas heart disease (HD) is a chronic fibrosing myocarditis with high mortality. The
PEACH study aimed to evaluate if exercise training can improve the functional capacity of …

Objectives To evaluate the quality of life (QoL) of patients with Chagas disease (CD) and the
association between QoL domains and several clinical, socioeconomic and lifestyle …

Reduced peak oxygen uptake (VO2peak) is a common clinical finding in progressive
Chagas disease. However, the disease stage in which functional impairment is detectable …

INTRODUCTION: Chagas cardiomyopathy (ChC) is highly stigmatized, and the presence of
depressive symptoms may be a common feature. However, its determinants remain unclear …